KatieB Posted February 26, 2018 Share Posted February 26, 2018 Last year, we shared exciting news about LUNGevity’s role in the Harvard Business School’s Kraft Precision Medicine Accelerator. The Accelerator is working to eliminate inefficiencies in precision medicine development to get targeted therapies to patients faster. The lung cancer community stepped up, participating in important research to get this project off the ground. Now we’re taking the research one step further – and we need insights from newly diagnosed patients. By taking this 10-15 minute survey, you’ll help the Accelerator team understand if this work is having a positive impact on patients’ access to the right treatments. They’ll use this information for critical adjustments to ensure patients are getting the best care possible. Your personal information and identity will be completely anonymous.http://surveys.globaltestmarket.com/survey/lsr/bmr/v3/91219082?hSampleSource=2#? LUNGevity, along with our partner foundations, want to express our deep gratitude for your continued support to help improve treatments for lung cancer patients. Quote Link to comment Share on other sites More sharing options...
BridgetO Posted February 27, 2018 Share Posted February 27, 2018 I did the survey. Interesting. Found out there was a lot I didn't know! Bridget O KatieB 1 Quote Link to comment Share on other sites More sharing options...
Tom Galli Posted February 27, 2018 Share Posted February 27, 2018 I tried but am not eligible..... Tom KatieB 1 Quote Link to comment Share on other sites More sharing options...
Robert Macaulay Posted February 27, 2018 Share Posted February 27, 2018 Same here not eligible...... It is intresting with the various health care systems That they seem to follow the same steps and procedures for care in Cancer treatment. KatieB 1 Quote Link to comment Share on other sites More sharing options...
Recommended Posts